Triple negative breast cancer : clinicopathological characteristics and treatment strategies
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-10-01
著者
-
Akiyama Futoshi
Department of Surgery and Pathology, Cancer Institute
-
IWASE Hirotaka
Department of Breast and Endocrine Surgery, Nagoya City University Medical School
-
Iwase Hirotaka
Department Of Breast And Endocrine Surgery Faculty Of Medical And Pharmaceutical Sciences Kumamoto U
-
Akiyama Futoshi
Department Of Breast Pathology Cancer Institute And Hospital Japanese Foundation For Cancer Research
-
Iwase Hirotaka
Department Of Breast And Endocrine Surgery Faculty Of Life Sciences Kumamoto University Graduate School Of Medical Sciences
-
AKIYAMA Futoshi
Department of Pathology, Cancer Institute
関連論文
- Allelic Losses of Loci at 3p25.1,8p22,13q12,17p13.3,and 22q13 Correlate with Postoperative Recurrence in Breast Cancer
- Mucocele-Like Tumor of the Breast Caused by Ductal Carcinoma in situ: A Case Report
- Histological Features of Breast Cancer, Highly Sensitive to Chemotherapy
- Clinical Usefulness of Oral Combination Chemotherapy of 5'-Deoxy-5-Fluorouridine (5'-DFUR) and Cyclophosphamide for Metastatic Breast Cancer
- Immunohistochemical Analysis on Biological Markers in Ductal Carcinoma in situ of the Breast
- Comparison of Five Different Antibodies in the Immunohistochmical Assay of Estrogen Receptor α in Human Breast Cancer
- Expression of Estrogen Receptor α Exon 5 and 7 Deletion Variant in Human Breast Cancers
- Allelic Loss at 1p34,13q12,17p13.3,and 17q21.1 Correlates With Poor Postoperative Prognosis in Breast Cancer
- Correlation of Allelic Loss with Poor Postoperative Survival in Breast Cancer
- Frequent Allelic Loss at 6q26-27 in Breast Carcinomas of the Solid-tubular Histologic Type
- Correlation of Allelic Losses and Clinicopathological Factors in Primary Breast Cancers
- Mapping of a Breast Cancer Tumor Suppressor Gene Locus to a 4-cM Interval on Chromosome 18q21
- Efficacy and Safety of Combined Trastuzumab and Paclitaxel Therapy as a Second-Line Treatment in Women with Metastatic Breast Cancer : A Single Institutional Experience
- High Prevalence of HER-2/neu and p53 Overexpression in Inflammatory Breast Cancer
- Dominant-negative Stat5 inhibits growth and induces apoptosis in T47D-derived tumors in nude mice
- Biweekly paclitaxel in patients with metastatic breast cancer
- Ratio of Expression of p16^ to p14^ Correlates with the Progression of Non-small Cell Lung Cancer
- Telomerase Activity Levels for Evaluating the Surgical Margin in Breast-Conserving Surgery
- Identification of Rad51 alteration in patients with bilateral breast cancer
- Assessment of hormone receptor status in breast cancer
- Muco-epidermoid carcinoma of the breast
- Present State of and Problems with Core Needle Biopsy for Non-Palpable Breast Lesions
- Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version)
- Correlation of Allelic Losses and Clinicopathological Factors in 504 Primary Breast Cancers
- Allelic Loss at 1p34-36 Predicts Poor Prognosis in Node-negative Breast Cancer
- Interobserver variation in the diagnosis of adenoma malignum (Minimal deviation adenocarcinoma) of the uterine cervix
- Issues in the Assessment of the Pathologic Effect of Primary Systemic Therapy for Breast Cancer
- Evaluation of interobserver agreement in scoring immunohistochemical results of HER-2/neu (c-erbB-2) expression detected by HercepTest, Nichirei polyclonal antibody, CB11 and TAB250 in breast carcinoma
- Evaluation of HER2 Status: For the Treatment of Metastatic Breast Cancers by Humanized Anti-HER2 Monoclonal Antibody (Trastuzumab) (Pathological Committee for Optimal Use of Trastuzumab)
- Surgery for Ductal Carcinoma in situ
- Diagnostic Mammography and Ultrasonography for Palpable and Nonpalpable Breast Cancer in Women Aged 30 to 39 Years
- Diagnostic Ultrasonography and Mammography for Invasive and Noninvasive Breast Cancer in Women Aged 30 to 39 Years
- Functional pathway characterized by gene expression analysis of supraclavicular lymph node metastasis-positive breast cancer
- What is the Predictor for Invasion in Non-palpable Breast Cancer with Microcalcifications?
- Mammographic and Clinicopathological Features of Mucinous Carcinoma of the Breast
- Clinical and Pathologic Features of Fibroadenoma of the Mastopathic Type
- Extension of Breast Cancer: Comparison of CT and MRI
- Successful management of breast cancer with liver metastases with medroxyprogesterone acetate treatment
- Clinical Significance of Estrogen Receptor β in Breast Cancer
- Surgical Margin Status as a Cause of Local Failure after Breast Conserving Therapy
- The Current Status of the Treatment of Ductal Carcinoma In Situ of Japanese Women, Especially Breast Conserving Operation in Relation to the Surgical Margin and Short Term Outcome
- Mapping of a New Target Region of Allelic Loss to a 2-cM Interval at 22q 13.1 in Primary Breast Cancer
- Endoscopic Classification of Intraductal Lesions and Histological Diagnosis
- Mutation Analysis of the mel-18 Gene that Shows Decreased Expression in Human Breast Cancer Cell Lines
- Evaluation of HER-2 Status in Breast Carcinoma by Fluorescence in situ Hybridization and Immunohistochemistry
- Allelic Loss on Chromosome 1p Is Associated with Progression and Lymph Node Metastasis of Primary Breast Carcinoma
- p33^ and Estrogen Receptor (ER) α
- Breast Pathology Slide Seminar Linked to Poster Presentations : A New Idea to Make Case Presentations in Medical Conferences More Interactive
- Alterations and Polymorphisms of the Estrogen Receptor Gene in Breast Cancer
- The Role of Stat5 in Estrogen Receptor-Positive Breast Cancer
- Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer
- Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer
- Molecular Action of the Estrogen Receptor and Hormone Dependency in Breast Cancer
- Mouse mammary gland reconstitution with extrinsic gene-transferred mammary epithelial cells in vitro and in vivo
- Clinicopathological features and treatment strategy for triple-negative breast cancer
- Estrogen receptor α gene ESR1 amplification may predict endocrine therapy responsiveness in breast cancer patients
- Advantage of Sentinel Lymph Node Biopsy Before Neoadjuvant Chemotherapy in Breast Cancer Treatment
- A Case Report of Paraneoplastic Neurological Syndrome Associated with Occult Breast Cancer
- Immunohistochemical Evaluation for Hormone Receptors in Breast Cancer : A Practically Useful Evaluation System and Handling Protocol
- Evaluation of the Interobserver Agreement in the Number of Mitotic Figures of Breast Carcinoma as Simulation of Quality Monitoring in the Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Protocol
- Triple negative breast cancer : clinicopathological characteristics and treatment strategies
- Ductal carcinoma in situ : correlations between high-resolution magnetic resonance imaging and histopathology
- A Comparison of MR Imaging, Galactography and Ultrasonography in Patients with Nipple Discharge
- Three-Dimensional MR Imaging of Mammographically Detected Suspicious Microcalcifications
- Clinical significance of basal-like subtype in triple-negative breast cancer
- Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model
- Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor
- Midkine in plasma as a novel breast cancer marker
- A quantitative model using mean and standard deviation for evaluation of interobserver agreement in nuclear atypia scoring of breast carcinomas in a protocol study
- Apocrine metaplasia of breast cancer : clinicopathological features and predicting response
- Carcinoma in a solitary intraductal papilloma of the breast
- Stromal Sarcoma of the Breast with Lung Metastases Showing a Clinical Complete Response to Doxorubicin plus Ifosfamide Treatment : Report of a Case
- Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer
- Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients
- MR and US imaging for breast cancer patients who underwent conservation surgery after neoadjuvant chemotherapy : comparison of triple negative breast cancer and other intrinsic subtypes
- Malignant transformation of breast fibroadenoma to malignant phyllodes tumor : long-term outcome of 36 malignant phyllodes tumors
- Time to first tumor progression as a predictor of efficacy of continued treatment with trastuzumab beyond progression in human epidermal growth factor receptor 2-positive metastatic breast cancer
- Breast cancer associated with mammary hamartoma
- Biweekly paclitaxel in patients with metastatic breast cancer
- Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer